Cargando…
Cerebrospinal Fluid Proteomics in Friedreich Ataxia Reveals Markers of Neurodegeneration and Neuroinflammation
Clinical trials in rare diseases as Friedreich ataxia (FRDA) offer special challenges, particularly when multiple treatments become ready for clinical testing. Regulatory health authorities have developed specific pathways for “orphan” drugs allowing the use of a validated biomarker for initial appr...
Autores principales: | Imbault, Virginie, Dionisi, Chiara, Naeije, Gilles, Communi, David, Pandolfo, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326443/ https://www.ncbi.nlm.nih.gov/pubmed/35911978 http://dx.doi.org/10.3389/fnins.2022.885313 |
Ejemplares similares
-
Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties
por: Dionisi, Chiara, et al.
Publicado: (2023) -
Cerebellar cognitive disorder parallels cerebellar motor symptoms in Friedreich ataxia
por: Naeije, Gilles, et al.
Publicado: (2020) -
Age of onset modulates resting‐state brain network dynamics in Friedreich Ataxia
por: Naeije, Gilles, et al.
Publicado: (2021) -
Age of onset determines intrinsic functional brain architecture in Friedreich ataxia
por: Naeije, Gilles, et al.
Publicado: (2019) -
Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)